ArticleNature communications2026
In-utero exposure to chikungunya and child morbimortality: a population-based study using linked routine data.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chikungunya exposure in-utero is linked to neonatal morbidity and neurodevelopmental effects. We examined the long-term morbidity associated with in-utero Chikungunya. This registry-based cohort study linked records of infants born in Brazil between 2015 and 2018, with all-cause first hospitalization and death as outcome. Infants were followed until the outcome, their third birthday, or the end of the study. Adjusted stratified Cox models were used to estimate hazard ratios (HR), 95% confidence intervals (95% CIs), and absolute risk differences. A total of 1,821 exposed and 18,210 unexposed infants were included. The HR for hospitalization was 1.21 (95% CI: 1.11-1.36), corresponding to 37 excess hospitalizations per 1000 exposed (95% CI: 16-64). The risk was twofold for intrapartum exposure (HR 2.08, 95% CI: 1.33-3.44) and elevated for first- and second-trimester exposure. Evidence for risk of death was limited. Here we show an elevated hospitalization risk associated with in-utero Chikungunya exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.